A year and a half after announcing their plans to build a state-of-the-art cell manufacturing facility in Frederick County, Maryland, Kite, a Gilead Company, is looking to fill dozens of new biomanufacturing jobs in Maryland and add to the talented site team it already has in place.
Top Seven Biotech Stock Gains in 2020 Linked to COVID-19
UMD Closes Biotechnology Research and Education Program (BREP) Amid Heightened Demand for Trained Biotech Graduates Recent Decision by the University of Maryland Administration Will Likely Have Unfortunate Impacts on Regional [….]
BioHealth Capital Region M&A Roundup First Half of 2020 It has been a tumultuous 2020 for venture capital and mergers and acquisitions due to the market uncertainty sparked by the [….]
2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region BioHealth Companies raised more than $178M in the first half of 2020 June 9, 2020 This [….]
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Companies
7 BioHealth Capital Region Diagnostics Companies Leading the Fight Against COVID-19
Photo Credit: Will Kirk / Johns Hopkins University Good News Stories Emerging from the Capital Region Show Solidarity Amid Coronavirus Endless social media scrolls, 24/7 news channels, newspapers, and radio [….]
BioHealth Capital Region Coronavirus Resources for Businesses and Employees – COVID-19
In Conversation: Sean Kirk, Emergent BioSolutions Following up on the recent article Two Maryland Biotechs Partner to Bring Coronavirus/COVID-19 Vaccine Candidate into Clinical Trials, BioBuzz had the opportunity to speak [….]
